2YP Stock Overview
Provides data and analytics technology and services to healthcare organizations in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Health Catalyst, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$7.05 |
| 52 Week High | US$10.10 |
| 52 Week Low | US$5.15 |
| Beta | 1.32 |
| 11 Month Change | -9.03% |
| 3 Month Change | 11.90% |
| 1 Year Change | 3.68% |
| 33 Year Change | -82.02% |
| 5 Year Change | n/a |
| Change since IPO | -68.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2YP | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | -5.4% | -2.0% | -0.2% |
| 1Y | 3.7% | -32.3% | 7.8% |
Return vs Industry: 2YP exceeded the German Healthcare Services industry which returned -32.3% over the past year.
Return vs Market: 2YP underperformed the German Market which returned 7.8% over the past year.
Price Volatility
| 2YP volatility | |
|---|---|
| 2YP Average Weekly Movement | 6.8% |
| Healthcare Services Industry Average Movement | 5.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2YP has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 2YP's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 1,300 | Dan Burton | www.healthcatalyst.com |
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.
Health Catalyst, Inc. Fundamentals Summary
| 2YP fundamental statistics | |
|---|---|
| Market cap | €435.30m |
| Earnings (TTM) | -€75.09m |
| Revenue (TTM) | €286.60m |
1.5x
P/S Ratio-5.7x
P/E RatioIs 2YP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2YP income statement (TTM) | |
|---|---|
| Revenue | US$302.06m |
| Cost of Revenue | US$162.59m |
| Gross Profit | US$139.47m |
| Other Expenses | US$218.61m |
| Earnings | -US$79.14m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.30 |
| Gross Margin | 46.17% |
| Net Profit Margin | -26.20% |
| Debt/Equity Ratio | 97.2% |
How did 2YP perform over the long term?
See historical performance and comparison